Covid-19 Impact on Pneumonia Market 2021-2025: Industry Insights and Growth by Top Key Company’s - GSK, Pfizer, Merck, Novartis, Sanofi, Eli Lilly
This report provides in-depth study of “Global Pneumonia Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Pneumonia Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Pneumonia is leading cause of death across the world with fatality rate of 4-10%. Hospital-acquired pneumonia is the most common form among the others and it has a huge impact on life style of patient population. Further, it is associated with a high mortality rate and requires immediate medical intervention. Because of this, there is a huge demand of pharmacological intervention ineffective management of the disease.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/279618 .
The most important key factors driving the growth of the Global Pneumonia Market are rapid growth in the incidence of pneumococcal disease, rising bacterial resistance of streptococcus bacteria, HIV associated pneumonia, increase in prevalence of pneumonia and government initiatives and growing prevalence of community-acquired pneumonia. According to the World Health Organization (WHO), pneumonia is responsible for majority of deaths in children worldwide. In 2015, 16% of children deaths under 5 years of age are due to pneumonia. Many antibiotics are currently available in the market to treat bacterial pneumonia conditions.
Regionally, North America is projected to dominate the over forecast period owing to high research activities on novel molecules and high deaths related to bacterial pneumonia conditions are attributing the growth of this market. APAC is expected to dominate the market due to increase in healthcare infrastructure and high prevalence of pneumonia in South Asia countries.
Global Key Vendors:
2 GlaxoSmithKline (GSK)
6 Eli Lilly and More……………….
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Pneumonia Market Report 2021” @ https://www.businessindustryreports.com/buy-now/279618/single .
Product Type Segmentation
3 Oxygen Therapy
2 Ambulatory Surgical Centers
Worldwide Medical Industry News:
Pfizer (March 26, 2021) - EMA Approves New Storage Option for Pfizer-Biontech Vaccine, Easing Distribution and Storage of Doses across European Union - Pfizer Inc. and BioNTech SE announced today that the European Medicines Agency (EMA) approved storage of COMIRNATY at -25°C to -15°C for a total of two weeks based on data showing the stability at these temperatures in standard pharmaceutical freezers. The new data is a testament to the companies’ ongoing commitment to developing this vaccine further and collecting data in order to support broader and more flexible vaccine distribution and inoculation.
With this approval, the COMIRNATY vials can be stored in all 27 European Union (EU) member states at these updated temperatures for a total of two weeks alternatively to the storage at ultra-low temperatures. It marks an important milestone in the vaccine roll-out, as it could allow storage in pharmacies to support vaccinations at local practices/doctors’ offices. By enabling more individuals to store and administer the vaccine, the approval will help broaden access, while limiting strain on larger vaccination centers.
“From the beginning our goal was to make our vaccine broadly available to people around the world. This approval by the EMA will enable us to access important additional channels to distribute and administer our vaccine,” said Ugur Sahin, CEO and Co-founder of BioNTech. “It comes at an important point in time, as governments now have more flexibility to move from inoculations in vaccination centers to a more decentralized vaccine roll-out through local doctors and general practitioners to accelerate our path out of the pandemic.”
“We appreciate the collaboration with the EMA and other regulatory agencies around the world as we work to ensure our vaccine can be shipped and stored under increasingly flexible conditions,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “This new storage option in Europe will help make the vaccine even more accessible to people across the continent, another important step as we continue our global fight against this virus.”
The vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States, United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.
The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564 (b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/279618 .
Major Points in Table of Contents:
Global Pneumonia Market Report 2021
1 Pneumonia Product Definition
2 Global Pneumonia Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Pneumonia Shipments
2.2 Global Manufacturer Pneumonia Business Revenue
2.3 Global Pneumonia Market Overview
2.4 COVID-19 Impact on Pneumonia Industry
3 Manufacturer Pneumonia Business Introduction
3.1 Pfizer Pneumonia Business Introduction
3.2 GlaxoSmithKline (GSK) Pneumonia Business Introduction
3.3 Merck Pneumonia Business Introduction
3.4 Novartis Pneumonia Business Introduction
3.5 Sanofi Pneumonia Business Introduction
3.6 Eli Lilly Pneumonia Business Introduction
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.
Business Industry Reports
Pune – India
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Covid-19 Impact on Pneumonia Market 2021-2025: Industry Insights and Growth by Top Key Company’s - GSK, Pfizer, Merck, Novartis, Sanofi, Eli Lilly here
News-ID: 2264936 • Views: 483
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast
More Releases for Pneumonia
Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth. Pneumonia is an
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,
Pneumonia Diagnostics Market worth US$ 685 Mn by 2027
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Pneumonia Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for pneumonia disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Community Acquired Pneumonia, Hospital Acquired Pneumonia and Ventilator Associated Pneumonia and features dormant and discontinued projects. Summary Community acquired pneumonia is pneumonia contracted by a person who has had little contact with the healthcare system, with common symptoms including cough, fever and
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ https://goo.gl/793aS1 The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.